Find Clinical and Medical Trials for Hepatitis C

<< Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next >>

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus - 10991
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV co-Infected Patients TDM Randomized Pilto Evaluation - 11150
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C - 11244
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation - 11486
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus - 11500
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation - 11503
Management of Hepatitis C in HIV-Infected and Uninfected IDUs - 13048
Safety and Efficacy of BMS-790052 Plus Standard of Care (Pegylated-Interferon Alpha and Ribavirin) - 13057
Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) - 13059
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy - 13073
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. - 13084
An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN) - 13091
Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C - 13097
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C - 13099
Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM - 13117

<< Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next >>